Skip to content

Drug interactions

Mifepristone + Paricalcitol

Severity: Minor

Mifepristone and Paricalcitol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone may raise paricalcitol exposure by inhibiting CYP3A4, one of the enzymes that metabolize it. The clinical effect is probably small, but excess vitamin D activity could cause hypercalcemia.

What this interaction means in plain words

Mifepristone and Paricalcitol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Mifepristone belongs to Endocrine; Paricalcitol belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Mifepristone inhibits CYP3A4, modestly reducing paricalcitol clearance.

What to do

Monitor serum calcium, phosphorus and PTH and adjust the paricalcitol dose as needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mifepristone and Paricalcitol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mifepristone with Paricalcitol?

MediHelp rates the interaction as minor. Mifepristone and Paricalcitol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Mifepristone may raise paricalcitol exposure by inhibiting CYP3A4, one of the enzymes that metabolize it. The clinical effect is probably small, but excess vitamin D activity could cause hypercalcemia.

How serious is the interaction between Mifepristone and Paricalcitol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum calcium, phosphorus and PTH and adjust the paricalcitol dose as needed.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in